Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Rongjing Zhao

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

zhao_rongjing_blog_150x150.png

zhao_rongjing_common_640x280.jpg

zhao_rongjing_heroretina_2700x1160.jpg

zhao_rongjing_mobileretina_750x1040.jpg

zhao_rongjing_social_600x600.jpg

Rongjing has extensive experience advising private equity firms, institutional investors and major corporations on complex cross-border transactions, including control deals and leveraged buyouts, mergers and acquisitions, growth capital investments, spin-offs, and distressed M&A transactions. She primarily represents private equity funds on investments and acquisitions in China and the rest of Asia. She also advises clients on take privates of U.S.-listed companies and other U.S. public and private company M&A transactions. 

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

Case Studies

ChinaBio® Partnering Forum: Top Five Risks and Opportunities to Watch in China Life Sciences in 2025

Navigating PE Trends in Asia: Insights for Investment Strategies 2025

Asia Technology Entrepreneurship Conference 2024 – Semi-Finalist Selections

ChinaBio® Partnering Forum 2024: Top Five Risks and Opportunities to Watch in China Life Sciences in the Coming Year

Global PE Trends 2023 and Outlook for 2024 - Asia Session

ChinaBio® Partnering Forum: Top 5 Risks and Opportunities to Watch in China Life Sciences in 2023

Events

Experience

Looking Beyond Silicon Valley: Global VC Terms Report (2025 Edition)

MoFo Global PE Trends 2024 and Outlook for 2025

纳斯达克提议修改低价股退市规则，上市公司需采取积极措施

回归故里——美股中概股私有化交易概述

Coming Home – Overview of Going Private Transactions of U.S.-Listed Chinese Companies

Proposed Changes in Penny Stock Delisting Rules: Proactive Steps Needed to Avoid Disruptions

Insights

Morrison Foerster Wins Two Awards at Law.com International’s 2025 Asia Legal Awards

Morrison Foerster Selected for Three 2024 Deals of the Year by China Business Law Journal

Morrison Foerster Named 2024 Law Firm of the Year in Asia Pacific: Transactions by PEI Awards

Three Morrison Foerster Partners Recognized at The Legal 500 China Awards 2024

DealStreetAsia

Nasdaq’s Clampdown Could Drive Chinese Penny Stock Firms Back Home

Asian Legal Business Names Rongjing Zhao as One of China’s Top 15 Female Lawyers

News

Responsible Tech for Asian PE Funds

Podcasts

Shanghai

Mergers + Acquisitions

Private Equity Investments + Buyouts

China

rzhao@mofo.com

86 (21) 23225215

MoFo Global PE Trends 2023 and Outlook Report 2024 - China Focus

Video + Audio

Rongjing Zhao

Insights

Insights

News

News

Events

Events

Video + Audio

Video + Audio

Podcasts

Podcasts

Recommended: China Life Sciences and Healthcare: Foreign Firms

Recommended: Hong Kong Corporate (Including M&A)

Private Equity: Foreign Firms Lawyer of the Year

Recommended China: Private Equity: Foreign Firms

Top 15 Female Lawyers

Recommended: China Corporate and M&A: Foreign Firms

Recommended: China Life Sciences and Healthcare: Foreign Firms

Recommended: Hong Kong Corporate (Including M&A)

Private Equity: Foreign Firms Lawyer of the Year

Recommended China: Private Equity: Foreign Firms

Top 15 Female Lawyers

Recommended: China Corporate and M&A: Foreign Firms

Recommended: China Life Sciences and Healthcare: Foreign Firms

Recommended: Hong Kong Corporate (Including M&A)